Theodore T. Wang

Dr. Wang has over 25 years of finance and investing experience. He was a Partner of Goldman Sachs where he held many leadership positions during his 18-year tenure at the firm. He joined Goldman Sachs in 1996 and was named Managing Director and Head of U.S. Convertibles Trading in 2002. In 2006 Dr. Wang was named a Partner and Co-Head of U.S. Stock Trading, Stock Options Trading, Convertibles Trading, Risk Arbitrage, and Franchise Risk Management. In 2009 he became Global Co-COO of One Delta Trading, and in 2012 became the unit's Global Co-Head as well as Co-Head of Equities Trading for the Americas.

Dr. Wang is a founding partner of Puissance Capital Management, primarily focusing on investing in innovative healthcare companies in the United States and China. He serves on the boards of Bellerophon Therapeutics, a NASDAQ listed company and Angel Pharmaceuticals, a privately held innovative biotech company in China he co-founded. He also serves as an independent director on the Audit Committee of Fiduciary Trust Company, a Division of Franklin Templeton. He is a founder of Angel Pond Capital LLC, a broker/dealer that provides advisory services in the life science sector. Dr. Wang holds a Ph.D in Physics from the University of Minnesota, an MBA from the University of Texas, Austin, and a B.S. from Fudan University, Shanghai, China. He is a trustee of the Dunhuang Foundation, and a member of Committee of 100, an organization of distinguished Chinese Americans with a mission to improve US-China relations.

Dr. Wang is the Chairman of our Board and a member of the Audit Committee.